Medical Devices & Consumables
Global The Human NK Cell Cytotoxicity Assay Kit Market Research Report 2026
- Feb 24, 26
- ID: 716857
- Pages: 133
- Figures: 129
- Views: 1
This report delivers a comprehensive overview of the global The Human NK Cell Cytotoxicity Assay Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding The Human NK Cell Cytotoxicity Assay Kit. The The Human NK Cell Cytotoxicity Assay Kit market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global The Human NK Cell Cytotoxicity Assay Kit market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist The Human NK Cell Cytotoxicity Assay Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Hillgene Biotech
Tongyu Biotech
Promega
Sartorius
R&D Systems
BD
Thermo Fisher Scientific
Abcam
Roche
Merck
Beckman Coulter
FUJIFILM
Arkray Factory
DiaSys Diagnostic Systems
Ortho-Clinical Diagnostics
Cell Signaling Technology
Beyotime
Nanjing Jiancheng Biotechnology
Applygen Technologies
Bestbio
Segment by Type
LDH Release Assay for Cytotoxicity
CCK8 Assay for Cytotoxicity
MTT Assay for Cytotoxicity
CAM-Labeled Target Cell Assay for Cytotoxicity
CFSE-Labeled Target Cell Assay for Cytotoxicity
by Application
Clinical
Research
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for The Human NK Cell Cytotoxicity Assay Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines The Human NK Cell Cytotoxicity Assay Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global The Human NK Cell Cytotoxicity Assay Kit market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist The Human NK Cell Cytotoxicity Assay Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Hillgene Biotech
Tongyu Biotech
Promega
Sartorius
R&D Systems
BD
Thermo Fisher Scientific
Abcam
Roche
Merck
Beckman Coulter
FUJIFILM
Arkray Factory
DiaSys Diagnostic Systems
Ortho-Clinical Diagnostics
Cell Signaling Technology
Beyotime
Nanjing Jiancheng Biotechnology
Applygen Technologies
Bestbio
Segment by Type
LDH Release Assay for Cytotoxicity
CCK8 Assay for Cytotoxicity
MTT Assay for Cytotoxicity
CAM-Labeled Target Cell Assay for Cytotoxicity
CFSE-Labeled Target Cell Assay for Cytotoxicity
by Application
Clinical
Research
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for The Human NK Cell Cytotoxicity Assay Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines The Human NK Cell Cytotoxicity Assay Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 The Human NK Cell Cytotoxicity Assay Kit Market Overview
1.1 Product Definition
1.2 The Human NK Cell Cytotoxicity Assay Kit by Type
1.2.1 Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Type: 2025 vs 2032
1.2.2 LDH Release Assay for Cytotoxicity
1.2.3 CCK8 Assay for Cytotoxicity
1.2.4 MTT Assay for Cytotoxicity
1.2.5 CAM-Labeled Target Cell Assay for Cytotoxicity
1.2.6 CFSE-Labeled Target Cell Assay for Cytotoxicity
1.3 The Human NK Cell Cytotoxicity Assay Kit by Application
1.3.1 Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Application: 2025 vs 2032
1.3.2 Clinical
1.3.3 Research
1.4 Global The Human NK Cell Cytotoxicity Assay Kit Market Size Estimates and Forecasts
1.4.1 Global The Human NK Cell Cytotoxicity Assay Kit Revenue 2021–2032
1.4.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales 2021–2032
1.4.3 Global The Human NK Cell Cytotoxicity Assay Kit Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 The Human NK Cell Cytotoxicity Assay Kit Market Competition by Manufacturers
2.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global The Human NK Cell Cytotoxicity Assay Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of The Human NK Cell Cytotoxicity Assay Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Product Types and Applications
2.7 Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Date of Entry into the Industry
2.8 Global The Human NK Cell Cytotoxicity Assay Kit Market Competitive Situation and Trends
2.8.1 Global The Human NK Cell Cytotoxicity Assay Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global The Human NK Cell Cytotoxicity Assay Kit Players Market Share by Revenue
2.8.3 Global The Human NK Cell Cytotoxicity Assay Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global The Human NK Cell Cytotoxicity Assay Kit Market Scenario by Region
3.1 Global The Human NK Cell Cytotoxicity Assay Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region: 2021–2032
3.2.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region: 2021–2026
3.2.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region: 2027–2032
3.3 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region: 2021–2032
3.3.1 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region: 2021–2026
3.3.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region: 2027–2032
3.4 North America The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Country
3.4.1 North America The Human NK Cell Cytotoxicity Assay Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (2021–2032)
3.4.3 North America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Country
3.5.1 Europe The Human NK Cell Cytotoxicity Assay Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe The Human NK Cell Cytotoxicity Assay Kit Sales by Country (2021–2032)
3.5.3 Europe The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Region
3.6.1 Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Country
3.7.1 Latin America The Human NK Cell Cytotoxicity Assay Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (2021–2032)
3.7.3 Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Type (2021–2032)
4.1.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Type (2021–2026)
4.1.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Type (2027–2032)
4.1.3 Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Type (2021–2032)
4.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Type (2021–2032)
4.2.1 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Type (2021–2026)
4.2.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Type (2027–2032)
4.2.3 Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Type (2021–2032)
4.3 Global The Human NK Cell Cytotoxicity Assay Kit Price by Type (2021–2032)
5 Segment by Application
5.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Application (2021–2032)
5.1.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Application (2021–2026)
5.1.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Application (2027–2032)
5.1.3 Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Application (2021–2032)
5.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Application (2021–2032)
5.2.1 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Application (2021–2026)
5.2.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Application (2027–2032)
5.2.3 Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Application (2021–2032)
5.3 Global The Human NK Cell Cytotoxicity Assay Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Hillgene Biotech
6.1.1 Hillgene Biotech Company Information
6.1.2 Hillgene Biotech Description and Business Overview
6.1.3 Hillgene Biotech The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Hillgene Biotech The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.1.5 Hillgene Biotech Recent Developments/Updates
6.2 Tongyu Biotech
6.2.1 Tongyu Biotech Company Information
6.2.2 Tongyu Biotech Description and Business Overview
6.2.3 Tongyu Biotech The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Tongyu Biotech The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.2.5 Tongyu Biotech Recent Developments/Updates
6.3 Promega
6.3.1 Promega Company Information
6.3.2 Promega Description and Business Overview
6.3.3 Promega The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Promega The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.3.5 Promega Recent Developments/Updates
6.4 Sartorius
6.4.1 Sartorius Company Information
6.4.2 Sartorius Description and Business Overview
6.4.3 Sartorius The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sartorius The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.4.5 Sartorius Recent Developments/Updates
6.5 R&D Systems
6.5.1 R&D Systems Company Information
6.5.2 R&D Systems Description and Business Overview
6.5.3 R&D Systems The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 R&D Systems The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.5.5 R&D Systems Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 BD The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Thermo Fisher Scientific
6.7.1 Thermo Fisher Scientific Company Information
6.7.2 Thermo Fisher Scientific Description and Business Overview
6.7.3 Thermo Fisher Scientific The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Thermo Fisher Scientific The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.7.5 Thermo Fisher Scientific Recent Developments/Updates
6.8 Abcam
6.8.1 Abcam Company Information
6.8.2 Abcam Description and Business Overview
6.8.3 Abcam The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Abcam The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.8.5 Abcam Recent Developments/Updates
6.9 Roche
6.9.1 Roche Company Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Roche The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Merck
6.10.1 Merck Company Information
6.10.2 Merck Description and Business Overview
6.10.3 Merck The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Merck The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.10.5 Merck Recent Developments/Updates
6.11 Beckman Coulter
6.11.1 Beckman Coulter Company Information
6.11.2 Beckman Coulter Description and Business Overview
6.11.3 Beckman Coulter The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Beckman Coulter The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.11.5 Beckman Coulter Recent Developments/Updates
6.12 FUJIFILM
6.12.1 FUJIFILM Company Information
6.12.2 FUJIFILM Description and Business Overview
6.12.3 FUJIFILM The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 FUJIFILM The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.12.5 FUJIFILM Recent Developments/Updates
6.13 Arkray Factory
6.13.1 Arkray Factory Company Information
6.13.2 Arkray Factory Description and Business Overview
6.13.3 Arkray Factory The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Arkray Factory The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.13.5 Arkray Factory Recent Developments/Updates
6.14 DiaSys Diagnostic Systems
6.14.1 DiaSys Diagnostic Systems Company Information
6.14.2 DiaSys Diagnostic Systems Description and Business Overview
6.14.3 DiaSys Diagnostic Systems The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 DiaSys Diagnostic Systems The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.14.5 DiaSys Diagnostic Systems Recent Developments/Updates
6.15 Ortho-Clinical Diagnostics
6.15.1 Ortho-Clinical Diagnostics Company Information
6.15.2 Ortho-Clinical Diagnostics Description and Business Overview
6.15.3 Ortho-Clinical Diagnostics The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Ortho-Clinical Diagnostics The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.15.5 Ortho-Clinical Diagnostics Recent Developments/Updates
6.16 Cell Signaling Technology
6.16.1 Cell Signaling Technology Company Information
6.16.2 Cell Signaling Technology Description and Business Overview
6.16.3 Cell Signaling Technology The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Cell Signaling Technology The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.16.5 Cell Signaling Technology Recent Developments/Updates
6.17 Beyotime
6.17.1 Beyotime Company Information
6.17.2 Beyotime Description and Business Overview
6.17.3 Beyotime The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Beyotime The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.17.5 Beyotime Recent Developments/Updates
6.18 Nanjing Jiancheng Biotechnology
6.18.1 Nanjing Jiancheng Biotechnology Company Information
6.18.2 Nanjing Jiancheng Biotechnology Description and Business Overview
6.18.3 Nanjing Jiancheng Biotechnology The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Nanjing Jiancheng Biotechnology The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.18.5 Nanjing Jiancheng Biotechnology Recent Developments/Updates
6.19 Applygen Technologies
6.19.1 Applygen Technologies Company Information
6.19.2 Applygen Technologies Description and Business Overview
6.19.3 Applygen Technologies The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Applygen Technologies The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.19.5 Applygen Technologies Recent Developments/Updates
6.20 Bestbio
6.20.1 Bestbio Company Information
6.20.2 Bestbio Description and Business Overview
6.20.3 Bestbio The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Bestbio The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.20.5 Bestbio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 The Human NK Cell Cytotoxicity Assay Kit Industry Chain Analysis
7.2 The Human NK Cell Cytotoxicity Assay Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 The Human NK Cell Cytotoxicity Assay Kit Production Mode & Process Analysis
7.4 The Human NK Cell Cytotoxicity Assay Kit Sales and Marketing
7.4.1 The Human NK Cell Cytotoxicity Assay Kit Sales Channels
7.4.2 The Human NK Cell Cytotoxicity Assay Kit Distributors
7.5 The Human NK Cell Cytotoxicity Assay Kit Customer Analysis
8 The Human NK Cell Cytotoxicity Assay Kit Market Dynamics
8.1 The Human NK Cell Cytotoxicity Assay Kit Industry Trends
8.2 The Human NK Cell Cytotoxicity Assay Kit Market Drivers
8.3 The Human NK Cell Cytotoxicity Assay Kit Market Challenges
8.4 The Human NK Cell Cytotoxicity Assay Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 The Human NK Cell Cytotoxicity Assay Kit by Type
1.2.1 Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Type: 2025 vs 2032
1.2.2 LDH Release Assay for Cytotoxicity
1.2.3 CCK8 Assay for Cytotoxicity
1.2.4 MTT Assay for Cytotoxicity
1.2.5 CAM-Labeled Target Cell Assay for Cytotoxicity
1.2.6 CFSE-Labeled Target Cell Assay for Cytotoxicity
1.3 The Human NK Cell Cytotoxicity Assay Kit by Application
1.3.1 Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Application: 2025 vs 2032
1.3.2 Clinical
1.3.3 Research
1.4 Global The Human NK Cell Cytotoxicity Assay Kit Market Size Estimates and Forecasts
1.4.1 Global The Human NK Cell Cytotoxicity Assay Kit Revenue 2021–2032
1.4.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales 2021–2032
1.4.3 Global The Human NK Cell Cytotoxicity Assay Kit Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 The Human NK Cell Cytotoxicity Assay Kit Market Competition by Manufacturers
2.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global The Human NK Cell Cytotoxicity Assay Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of The Human NK Cell Cytotoxicity Assay Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Product Types and Applications
2.7 Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Date of Entry into the Industry
2.8 Global The Human NK Cell Cytotoxicity Assay Kit Market Competitive Situation and Trends
2.8.1 Global The Human NK Cell Cytotoxicity Assay Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global The Human NK Cell Cytotoxicity Assay Kit Players Market Share by Revenue
2.8.3 Global The Human NK Cell Cytotoxicity Assay Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global The Human NK Cell Cytotoxicity Assay Kit Market Scenario by Region
3.1 Global The Human NK Cell Cytotoxicity Assay Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region: 2021–2032
3.2.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region: 2021–2026
3.2.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region: 2027–2032
3.3 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region: 2021–2032
3.3.1 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region: 2021–2026
3.3.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region: 2027–2032
3.4 North America The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Country
3.4.1 North America The Human NK Cell Cytotoxicity Assay Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (2021–2032)
3.4.3 North America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Country
3.5.1 Europe The Human NK Cell Cytotoxicity Assay Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe The Human NK Cell Cytotoxicity Assay Kit Sales by Country (2021–2032)
3.5.3 Europe The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Region
3.6.1 Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Country
3.7.1 Latin America The Human NK Cell Cytotoxicity Assay Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (2021–2032)
3.7.3 Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Type (2021–2032)
4.1.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Type (2021–2026)
4.1.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Type (2027–2032)
4.1.3 Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Type (2021–2032)
4.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Type (2021–2032)
4.2.1 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Type (2021–2026)
4.2.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Type (2027–2032)
4.2.3 Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Type (2021–2032)
4.3 Global The Human NK Cell Cytotoxicity Assay Kit Price by Type (2021–2032)
5 Segment by Application
5.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Application (2021–2032)
5.1.1 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Application (2021–2026)
5.1.2 Global The Human NK Cell Cytotoxicity Assay Kit Sales by Application (2027–2032)
5.1.3 Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Application (2021–2032)
5.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Application (2021–2032)
5.2.1 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Application (2021–2026)
5.2.2 Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Application (2027–2032)
5.2.3 Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Application (2021–2032)
5.3 Global The Human NK Cell Cytotoxicity Assay Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Hillgene Biotech
6.1.1 Hillgene Biotech Company Information
6.1.2 Hillgene Biotech Description and Business Overview
6.1.3 Hillgene Biotech The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Hillgene Biotech The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.1.5 Hillgene Biotech Recent Developments/Updates
6.2 Tongyu Biotech
6.2.1 Tongyu Biotech Company Information
6.2.2 Tongyu Biotech Description and Business Overview
6.2.3 Tongyu Biotech The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Tongyu Biotech The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.2.5 Tongyu Biotech Recent Developments/Updates
6.3 Promega
6.3.1 Promega Company Information
6.3.2 Promega Description and Business Overview
6.3.3 Promega The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Promega The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.3.5 Promega Recent Developments/Updates
6.4 Sartorius
6.4.1 Sartorius Company Information
6.4.2 Sartorius Description and Business Overview
6.4.3 Sartorius The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sartorius The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.4.5 Sartorius Recent Developments/Updates
6.5 R&D Systems
6.5.1 R&D Systems Company Information
6.5.2 R&D Systems Description and Business Overview
6.5.3 R&D Systems The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 R&D Systems The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.5.5 R&D Systems Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 BD The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Thermo Fisher Scientific
6.7.1 Thermo Fisher Scientific Company Information
6.7.2 Thermo Fisher Scientific Description and Business Overview
6.7.3 Thermo Fisher Scientific The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Thermo Fisher Scientific The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.7.5 Thermo Fisher Scientific Recent Developments/Updates
6.8 Abcam
6.8.1 Abcam Company Information
6.8.2 Abcam Description and Business Overview
6.8.3 Abcam The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Abcam The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.8.5 Abcam Recent Developments/Updates
6.9 Roche
6.9.1 Roche Company Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Roche The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Merck
6.10.1 Merck Company Information
6.10.2 Merck Description and Business Overview
6.10.3 Merck The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Merck The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.10.5 Merck Recent Developments/Updates
6.11 Beckman Coulter
6.11.1 Beckman Coulter Company Information
6.11.2 Beckman Coulter Description and Business Overview
6.11.3 Beckman Coulter The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Beckman Coulter The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.11.5 Beckman Coulter Recent Developments/Updates
6.12 FUJIFILM
6.12.1 FUJIFILM Company Information
6.12.2 FUJIFILM Description and Business Overview
6.12.3 FUJIFILM The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 FUJIFILM The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.12.5 FUJIFILM Recent Developments/Updates
6.13 Arkray Factory
6.13.1 Arkray Factory Company Information
6.13.2 Arkray Factory Description and Business Overview
6.13.3 Arkray Factory The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Arkray Factory The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.13.5 Arkray Factory Recent Developments/Updates
6.14 DiaSys Diagnostic Systems
6.14.1 DiaSys Diagnostic Systems Company Information
6.14.2 DiaSys Diagnostic Systems Description and Business Overview
6.14.3 DiaSys Diagnostic Systems The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 DiaSys Diagnostic Systems The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.14.5 DiaSys Diagnostic Systems Recent Developments/Updates
6.15 Ortho-Clinical Diagnostics
6.15.1 Ortho-Clinical Diagnostics Company Information
6.15.2 Ortho-Clinical Diagnostics Description and Business Overview
6.15.3 Ortho-Clinical Diagnostics The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Ortho-Clinical Diagnostics The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.15.5 Ortho-Clinical Diagnostics Recent Developments/Updates
6.16 Cell Signaling Technology
6.16.1 Cell Signaling Technology Company Information
6.16.2 Cell Signaling Technology Description and Business Overview
6.16.3 Cell Signaling Technology The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Cell Signaling Technology The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.16.5 Cell Signaling Technology Recent Developments/Updates
6.17 Beyotime
6.17.1 Beyotime Company Information
6.17.2 Beyotime Description and Business Overview
6.17.3 Beyotime The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Beyotime The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.17.5 Beyotime Recent Developments/Updates
6.18 Nanjing Jiancheng Biotechnology
6.18.1 Nanjing Jiancheng Biotechnology Company Information
6.18.2 Nanjing Jiancheng Biotechnology Description and Business Overview
6.18.3 Nanjing Jiancheng Biotechnology The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Nanjing Jiancheng Biotechnology The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.18.5 Nanjing Jiancheng Biotechnology Recent Developments/Updates
6.19 Applygen Technologies
6.19.1 Applygen Technologies Company Information
6.19.2 Applygen Technologies Description and Business Overview
6.19.3 Applygen Technologies The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Applygen Technologies The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.19.5 Applygen Technologies Recent Developments/Updates
6.20 Bestbio
6.20.1 Bestbio Company Information
6.20.2 Bestbio Description and Business Overview
6.20.3 Bestbio The Human NK Cell Cytotoxicity Assay Kit Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Bestbio The Human NK Cell Cytotoxicity Assay Kit Product Portfolio
6.20.5 Bestbio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 The Human NK Cell Cytotoxicity Assay Kit Industry Chain Analysis
7.2 The Human NK Cell Cytotoxicity Assay Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 The Human NK Cell Cytotoxicity Assay Kit Production Mode & Process Analysis
7.4 The Human NK Cell Cytotoxicity Assay Kit Sales and Marketing
7.4.1 The Human NK Cell Cytotoxicity Assay Kit Sales Channels
7.4.2 The Human NK Cell Cytotoxicity Assay Kit Distributors
7.5 The Human NK Cell Cytotoxicity Assay Kit Customer Analysis
8 The Human NK Cell Cytotoxicity Assay Kit Market Dynamics
8.1 The Human NK Cell Cytotoxicity Assay Kit Industry Trends
8.2 The Human NK Cell Cytotoxicity Assay Kit Market Drivers
8.3 The Human NK Cell Cytotoxicity Assay Kit Market Challenges
8.4 The Human NK Cell Cytotoxicity Assay Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global The Human NK Cell Cytotoxicity Assay Kit Market Competitive Situation by Manufacturers in 2025
Table 4. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Manufacturers (2021–2026)
Table 6. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market The Human NK Cell Cytotoxicity Assay Kit Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of The Human NK Cell Cytotoxicity Assay Kit, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Product Types and Applications
Table 12. Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global The Human NK Cell Cytotoxicity Assay Kit Companies by Tier (Tier 1, Tier 2, Tier 3), based on The Human NK Cell Cytotoxicity Assay Kit Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global The Human NK Cell Cytotoxicity Assay Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region (K Units), 2021–2026
Table 18. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Region (2021–2026)
Table 19. Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region (K Units), 2027–2032
Table 20. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Region (2027–2032)
Table 21. Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (US$ Million), 2021–2026
Table 22. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Region (2021–2026)
Table 23. Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (US$ Million), 2027–2032
Table 24. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Region (2027–2032)
Table 25. North America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2021–2026
Table 27. North America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2027–2032
Table 28. North America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2021–2026
Table 29. North America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2027–2032
Table 30. Europe The Human NK Cell Cytotoxicity Assay Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2021–2026
Table 32. Europe The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2027–2032
Table 33. Europe The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2021–2026
Table 34. Europe The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2021–2026
Table 42. Latin America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2027–2032
Table 43. Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2027–2032
Table 50. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) by Type (2021–2026)
Table 51. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) by Type (2027–2032)
Table 52. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Type (2021–2026)
Table 53. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Type (2027–2032)
Table 54. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Type (2021–2026)
Table 55. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Type (2027–2032)
Table 56. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Type (2021–2026)
Table 57. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Type (2027–2032)
Table 58. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Type (2021–2026)
Table 59. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Type (2027–2032)
Table 60. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) by Application (2021–2026)
Table 61. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) by Application (2027–2032)
Table 62. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Application (2021–2026)
Table 63. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Application (2027–2032)
Table 64. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Application (2021–2026)
Table 65. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Application (2027–2032)
Table 66. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Application (2021–2026)
Table 67. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Application (2027–2032)
Table 68. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Application (2021–2026)
Table 69. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Application (2027–2032)
Table 70. Hillgene Biotech Company Information
Table 71. Hillgene Biotech Description and Business Overview
Table 72. Hillgene Biotech The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Hillgene Biotech The Human NK Cell Cytotoxicity Assay Kit Product
Table 74. Hillgene Biotech Recent Developments/Updates
Table 75. Tongyu Biotech Company Information
Table 76. Tongyu Biotech Description and Business Overview
Table 77. Tongyu Biotech The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Tongyu Biotech The Human NK Cell Cytotoxicity Assay Kit Product
Table 79. Tongyu Biotech Recent Developments/Updates
Table 80. Promega Company Information
Table 81. Promega Description and Business Overview
Table 82. Promega The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Promega The Human NK Cell Cytotoxicity Assay Kit Product
Table 84. Promega Recent Developments/Updates
Table 85. Sartorius Company Information
Table 86. Sartorius Description and Business Overview
Table 87. Sartorius The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sartorius The Human NK Cell Cytotoxicity Assay Kit Product
Table 89. Sartorius Recent Developments/Updates
Table 90. R&D Systems Company Information
Table 91. R&D Systems Description and Business Overview
Table 92. R&D Systems The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. R&D Systems The Human NK Cell Cytotoxicity Assay Kit Product
Table 94. R&D Systems Recent Developments/Updates
Table 95. BD Company Information
Table 96. BD Description and Business Overview
Table 97. BD The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. BD The Human NK Cell Cytotoxicity Assay Kit Product
Table 99. BD Recent Developments/Updates
Table 100. Thermo Fisher Scientific Company Information
Table 101. Thermo Fisher Scientific Description and Business Overview
Table 102. Thermo Fisher Scientific The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Thermo Fisher Scientific The Human NK Cell Cytotoxicity Assay Kit Product
Table 104. Thermo Fisher Scientific Recent Developments/Updates
Table 105. Abcam Company Information
Table 106. Abcam Description and Business Overview
Table 107. Abcam The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Abcam The Human NK Cell Cytotoxicity Assay Kit Product
Table 109. Abcam Recent Developments/Updates
Table 110. Roche Company Information
Table 111. Roche Description and Business Overview
Table 112. Roche The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Roche The Human NK Cell Cytotoxicity Assay Kit Product
Table 114. Roche Recent Developments/Updates
Table 115. Merck Company Information
Table 116. Merck Description and Business Overview
Table 117. Merck The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Merck The Human NK Cell Cytotoxicity Assay Kit Product
Table 119. Merck Recent Developments/Updates
Table 120. Beckman Coulter Company Information
Table 121. Beckman Coulter Description and Business Overview
Table 122. Beckman Coulter The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Beckman Coulter The Human NK Cell Cytotoxicity Assay Kit Product
Table 124. Beckman Coulter Recent Developments/Updates
Table 125. FUJIFILM Company Information
Table 126. FUJIFILM Description and Business Overview
Table 127. FUJIFILM The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. FUJIFILM The Human NK Cell Cytotoxicity Assay Kit Product
Table 129. FUJIFILM Recent Developments/Updates
Table 130. Arkray Factory Company Information
Table 131. Arkray Factory Description and Business Overview
Table 132. Arkray Factory The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Arkray Factory The Human NK Cell Cytotoxicity Assay Kit Product
Table 134. Arkray Factory Recent Developments/Updates
Table 135. DiaSys Diagnostic Systems Company Information
Table 136. DiaSys Diagnostic Systems Description and Business Overview
Table 137. DiaSys Diagnostic Systems The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. DiaSys Diagnostic Systems The Human NK Cell Cytotoxicity Assay Kit Product
Table 139. DiaSys Diagnostic Systems Recent Developments/Updates
Table 140. Ortho-Clinical Diagnostics Company Information
Table 141. Ortho-Clinical Diagnostics Description and Business Overview
Table 142. Ortho-Clinical Diagnostics The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Ortho-Clinical Diagnostics The Human NK Cell Cytotoxicity Assay Kit Product
Table 144. Ortho-Clinical Diagnostics Recent Developments/Updates
Table 145. Cell Signaling Technology Company Information
Table 146. Cell Signaling Technology Description and Business Overview
Table 147. Cell Signaling Technology The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Cell Signaling Technology The Human NK Cell Cytotoxicity Assay Kit Product
Table 149. Cell Signaling Technology Recent Developments/Updates
Table 150. Beyotime Company Information
Table 151. Beyotime Description and Business Overview
Table 152. Beyotime The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Beyotime The Human NK Cell Cytotoxicity Assay Kit Product
Table 154. Beyotime Recent Developments/Updates
Table 155. Nanjing Jiancheng Biotechnology Company Information
Table 156. Nanjing Jiancheng Biotechnology Description and Business Overview
Table 157. Nanjing Jiancheng Biotechnology The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Nanjing Jiancheng Biotechnology The Human NK Cell Cytotoxicity Assay Kit Product
Table 159. Nanjing Jiancheng Biotechnology Recent Developments/Updates
Table 160. Applygen Technologies Company Information
Table 161. Applygen Technologies Description and Business Overview
Table 162. Applygen Technologies The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Applygen Technologies The Human NK Cell Cytotoxicity Assay Kit Product
Table 164. Applygen Technologies Recent Developments/Updates
Table 165. Bestbio Company Information
Table 166. Bestbio Description and Business Overview
Table 167. Bestbio The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Bestbio The Human NK Cell Cytotoxicity Assay Kit Product
Table 169. Bestbio Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. The Human NK Cell Cytotoxicity Assay Kit Distributors List
Table 173. The Human NK Cell Cytotoxicity Assay Kit Customers List
Table 174. The Human NK Cell Cytotoxicity Assay Kit Market Trends
Table 175. The Human NK Cell Cytotoxicity Assay Kit Market Drivers
Table 176. The Human NK Cell Cytotoxicity Assay Kit Market Challenges
Table 177. The Human NK Cell Cytotoxicity Assay Kit Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of The Human NK Cell Cytotoxicity Assay Kit
Figure 2. Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Type (US$ Million), 2021–2032
Figure 3. Global The Human NK Cell Cytotoxicity Assay Kit Market Share by Type: 2025 & 2032
Figure 4. LDH Release Assay for Cytotoxicity Product Picture
Figure 5. CCK8 Assay for Cytotoxicity Product Picture
Figure 6. MTT Assay for Cytotoxicity Product Picture
Figure 7. CAM-Labeled Target Cell Assay for Cytotoxicity Product Picture
Figure 8. CFSE-Labeled Target Cell Assay for Cytotoxicity Product Picture
Figure 9. Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Application (US$ Million), 2021–2032
Figure 10. Global The Human NK Cell Cytotoxicity Assay Kit Market Share by Application: 2025 & 2032
Figure 11. Clinical
Figure 12. Research
Figure 13. Global The Human NK Cell Cytotoxicity Assay Kit Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global The Human NK Cell Cytotoxicity Assay Kit Market Size (US$ Million), 2021–2032
Figure 15. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), 2021–2032
Figure 16. Global The Human NK Cell Cytotoxicity Assay Kit Average Price (US$/Unit), 2021–2032
Figure 17. The Human NK Cell Cytotoxicity Assay Kit Report Years Considered
Figure 18. The Human NK Cell Cytotoxicity Assay Kit Sales Share by Manufacturers in 2025
Figure 19. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global The Human NK Cell Cytotoxicity Assay Kit Players: Market Share by Revenue in The Human NK Cell Cytotoxicity Assay Kit in 2025
Figure 21. The Human NK Cell Cytotoxicity Assay Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global The Human NK Cell Cytotoxicity Assay Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Country (2021–2032)
Figure 24. North America The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Country (2021–2032)
Figure 25. United States The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Country (2021–2032)
Figure 28. Europe The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Country (2021–2032)
Figure 29. Germany The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Region (2021–2032)
Figure 36. China The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Country (2021–2032)
Figure 44. Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Country (2021–2032)
Figure 45. Mexico The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Country (2021–2032)
Figure 51. Turkey The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of The Human NK Cell Cytotoxicity Assay Kit by Type (2021–2032)
Figure 55. Global Revenue Market Share of The Human NK Cell Cytotoxicity Assay Kit by Type (2021–2032)
Figure 56. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of The Human NK Cell Cytotoxicity Assay Kit by Application (2021–2032)
Figure 58. Global Revenue Market Share of The Human NK Cell Cytotoxicity Assay Kit by Application (2021–2032)
Figure 59. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Application (2021–2032)
Figure 60. The Human NK Cell Cytotoxicity Assay Kit Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global The Human NK Cell Cytotoxicity Assay Kit Market Competitive Situation by Manufacturers in 2025
Table 4. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Manufacturers (2021–2026)
Table 6. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market The Human NK Cell Cytotoxicity Assay Kit Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of The Human NK Cell Cytotoxicity Assay Kit, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Product Types and Applications
Table 12. Global Key Manufacturers of The Human NK Cell Cytotoxicity Assay Kit, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global The Human NK Cell Cytotoxicity Assay Kit Companies by Tier (Tier 1, Tier 2, Tier 3), based on The Human NK Cell Cytotoxicity Assay Kit Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global The Human NK Cell Cytotoxicity Assay Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region (K Units), 2021–2026
Table 18. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Region (2021–2026)
Table 19. Global The Human NK Cell Cytotoxicity Assay Kit Sales by Region (K Units), 2027–2032
Table 20. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Region (2027–2032)
Table 21. Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (US$ Million), 2021–2026
Table 22. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Region (2021–2026)
Table 23. Global The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (US$ Million), 2027–2032
Table 24. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Region (2027–2032)
Table 25. North America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2021–2026
Table 27. North America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2027–2032
Table 28. North America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2021–2026
Table 29. North America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2027–2032
Table 30. Europe The Human NK Cell Cytotoxicity Assay Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2021–2026
Table 32. Europe The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2027–2032
Table 33. Europe The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2021–2026
Table 34. Europe The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2021–2026
Table 42. Latin America The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2027–2032
Table 43. Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue by Country (US$ Million), 2027–2032
Table 50. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) by Type (2021–2026)
Table 51. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) by Type (2027–2032)
Table 52. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Type (2021–2026)
Table 53. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Type (2027–2032)
Table 54. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Type (2021–2026)
Table 55. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Type (2027–2032)
Table 56. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Type (2021–2026)
Table 57. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Type (2027–2032)
Table 58. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Type (2021–2026)
Table 59. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Type (2027–2032)
Table 60. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) by Application (2021–2026)
Table 61. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units) by Application (2027–2032)
Table 62. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Application (2021–2026)
Table 63. Global The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Application (2027–2032)
Table 64. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Application (2021–2026)
Table 65. Global The Human NK Cell Cytotoxicity Assay Kit Revenue (US$ Million) by Application (2027–2032)
Table 66. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Application (2021–2026)
Table 67. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Application (2027–2032)
Table 68. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Application (2021–2026)
Table 69. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Application (2027–2032)
Table 70. Hillgene Biotech Company Information
Table 71. Hillgene Biotech Description and Business Overview
Table 72. Hillgene Biotech The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Hillgene Biotech The Human NK Cell Cytotoxicity Assay Kit Product
Table 74. Hillgene Biotech Recent Developments/Updates
Table 75. Tongyu Biotech Company Information
Table 76. Tongyu Biotech Description and Business Overview
Table 77. Tongyu Biotech The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Tongyu Biotech The Human NK Cell Cytotoxicity Assay Kit Product
Table 79. Tongyu Biotech Recent Developments/Updates
Table 80. Promega Company Information
Table 81. Promega Description and Business Overview
Table 82. Promega The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Promega The Human NK Cell Cytotoxicity Assay Kit Product
Table 84. Promega Recent Developments/Updates
Table 85. Sartorius Company Information
Table 86. Sartorius Description and Business Overview
Table 87. Sartorius The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sartorius The Human NK Cell Cytotoxicity Assay Kit Product
Table 89. Sartorius Recent Developments/Updates
Table 90. R&D Systems Company Information
Table 91. R&D Systems Description and Business Overview
Table 92. R&D Systems The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. R&D Systems The Human NK Cell Cytotoxicity Assay Kit Product
Table 94. R&D Systems Recent Developments/Updates
Table 95. BD Company Information
Table 96. BD Description and Business Overview
Table 97. BD The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. BD The Human NK Cell Cytotoxicity Assay Kit Product
Table 99. BD Recent Developments/Updates
Table 100. Thermo Fisher Scientific Company Information
Table 101. Thermo Fisher Scientific Description and Business Overview
Table 102. Thermo Fisher Scientific The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Thermo Fisher Scientific The Human NK Cell Cytotoxicity Assay Kit Product
Table 104. Thermo Fisher Scientific Recent Developments/Updates
Table 105. Abcam Company Information
Table 106. Abcam Description and Business Overview
Table 107. Abcam The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Abcam The Human NK Cell Cytotoxicity Assay Kit Product
Table 109. Abcam Recent Developments/Updates
Table 110. Roche Company Information
Table 111. Roche Description and Business Overview
Table 112. Roche The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Roche The Human NK Cell Cytotoxicity Assay Kit Product
Table 114. Roche Recent Developments/Updates
Table 115. Merck Company Information
Table 116. Merck Description and Business Overview
Table 117. Merck The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Merck The Human NK Cell Cytotoxicity Assay Kit Product
Table 119. Merck Recent Developments/Updates
Table 120. Beckman Coulter Company Information
Table 121. Beckman Coulter Description and Business Overview
Table 122. Beckman Coulter The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Beckman Coulter The Human NK Cell Cytotoxicity Assay Kit Product
Table 124. Beckman Coulter Recent Developments/Updates
Table 125. FUJIFILM Company Information
Table 126. FUJIFILM Description and Business Overview
Table 127. FUJIFILM The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. FUJIFILM The Human NK Cell Cytotoxicity Assay Kit Product
Table 129. FUJIFILM Recent Developments/Updates
Table 130. Arkray Factory Company Information
Table 131. Arkray Factory Description and Business Overview
Table 132. Arkray Factory The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Arkray Factory The Human NK Cell Cytotoxicity Assay Kit Product
Table 134. Arkray Factory Recent Developments/Updates
Table 135. DiaSys Diagnostic Systems Company Information
Table 136. DiaSys Diagnostic Systems Description and Business Overview
Table 137. DiaSys Diagnostic Systems The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. DiaSys Diagnostic Systems The Human NK Cell Cytotoxicity Assay Kit Product
Table 139. DiaSys Diagnostic Systems Recent Developments/Updates
Table 140. Ortho-Clinical Diagnostics Company Information
Table 141. Ortho-Clinical Diagnostics Description and Business Overview
Table 142. Ortho-Clinical Diagnostics The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Ortho-Clinical Diagnostics The Human NK Cell Cytotoxicity Assay Kit Product
Table 144. Ortho-Clinical Diagnostics Recent Developments/Updates
Table 145. Cell Signaling Technology Company Information
Table 146. Cell Signaling Technology Description and Business Overview
Table 147. Cell Signaling Technology The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Cell Signaling Technology The Human NK Cell Cytotoxicity Assay Kit Product
Table 149. Cell Signaling Technology Recent Developments/Updates
Table 150. Beyotime Company Information
Table 151. Beyotime Description and Business Overview
Table 152. Beyotime The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Beyotime The Human NK Cell Cytotoxicity Assay Kit Product
Table 154. Beyotime Recent Developments/Updates
Table 155. Nanjing Jiancheng Biotechnology Company Information
Table 156. Nanjing Jiancheng Biotechnology Description and Business Overview
Table 157. Nanjing Jiancheng Biotechnology The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Nanjing Jiancheng Biotechnology The Human NK Cell Cytotoxicity Assay Kit Product
Table 159. Nanjing Jiancheng Biotechnology Recent Developments/Updates
Table 160. Applygen Technologies Company Information
Table 161. Applygen Technologies Description and Business Overview
Table 162. Applygen Technologies The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Applygen Technologies The Human NK Cell Cytotoxicity Assay Kit Product
Table 164. Applygen Technologies Recent Developments/Updates
Table 165. Bestbio Company Information
Table 166. Bestbio Description and Business Overview
Table 167. Bestbio The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Bestbio The Human NK Cell Cytotoxicity Assay Kit Product
Table 169. Bestbio Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. The Human NK Cell Cytotoxicity Assay Kit Distributors List
Table 173. The Human NK Cell Cytotoxicity Assay Kit Customers List
Table 174. The Human NK Cell Cytotoxicity Assay Kit Market Trends
Table 175. The Human NK Cell Cytotoxicity Assay Kit Market Drivers
Table 176. The Human NK Cell Cytotoxicity Assay Kit Market Challenges
Table 177. The Human NK Cell Cytotoxicity Assay Kit Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of The Human NK Cell Cytotoxicity Assay Kit
Figure 2. Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Type (US$ Million), 2021–2032
Figure 3. Global The Human NK Cell Cytotoxicity Assay Kit Market Share by Type: 2025 & 2032
Figure 4. LDH Release Assay for Cytotoxicity Product Picture
Figure 5. CCK8 Assay for Cytotoxicity Product Picture
Figure 6. MTT Assay for Cytotoxicity Product Picture
Figure 7. CAM-Labeled Target Cell Assay for Cytotoxicity Product Picture
Figure 8. CFSE-Labeled Target Cell Assay for Cytotoxicity Product Picture
Figure 9. Global The Human NK Cell Cytotoxicity Assay Kit Market Value by Application (US$ Million), 2021–2032
Figure 10. Global The Human NK Cell Cytotoxicity Assay Kit Market Share by Application: 2025 & 2032
Figure 11. Clinical
Figure 12. Research
Figure 13. Global The Human NK Cell Cytotoxicity Assay Kit Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global The Human NK Cell Cytotoxicity Assay Kit Market Size (US$ Million), 2021–2032
Figure 15. Global The Human NK Cell Cytotoxicity Assay Kit Sales (K Units), 2021–2032
Figure 16. Global The Human NK Cell Cytotoxicity Assay Kit Average Price (US$/Unit), 2021–2032
Figure 17. The Human NK Cell Cytotoxicity Assay Kit Report Years Considered
Figure 18. The Human NK Cell Cytotoxicity Assay Kit Sales Share by Manufacturers in 2025
Figure 19. Global The Human NK Cell Cytotoxicity Assay Kit Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global The Human NK Cell Cytotoxicity Assay Kit Players: Market Share by Revenue in The Human NK Cell Cytotoxicity Assay Kit in 2025
Figure 21. The Human NK Cell Cytotoxicity Assay Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global The Human NK Cell Cytotoxicity Assay Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Country (2021–2032)
Figure 24. North America The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Country (2021–2032)
Figure 25. United States The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Country (2021–2032)
Figure 28. Europe The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Country (2021–2032)
Figure 29. Germany The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Region (2021–2032)
Figure 36. China The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Country (2021–2032)
Figure 44. Latin America The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Country (2021–2032)
Figure 45. Mexico The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa The Human NK Cell Cytotoxicity Assay Kit Revenue Market Share by Country (2021–2032)
Figure 51. Turkey The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE The Human NK Cell Cytotoxicity Assay Kit Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of The Human NK Cell Cytotoxicity Assay Kit by Type (2021–2032)
Figure 55. Global Revenue Market Share of The Human NK Cell Cytotoxicity Assay Kit by Type (2021–2032)
Figure 56. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of The Human NK Cell Cytotoxicity Assay Kit by Application (2021–2032)
Figure 58. Global Revenue Market Share of The Human NK Cell Cytotoxicity Assay Kit by Application (2021–2032)
Figure 59. Global The Human NK Cell Cytotoxicity Assay Kit Price (US$/Unit) by Application (2021–2032)
Figure 60. The Human NK Cell Cytotoxicity Assay Kit Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232